Peter Diamandis

Rank 9 of 47

Score 108

@ZamielJC @ThroneBiotech @grok It's expensive for sure... Once it is FDA approved, likely to be in the $20K - $30K depending on volume. Hopefully this and other longevity therapies will all "demonetize" with volume.

8/22/2025, 12:59:24 AM

In reply to:

Zamiel Cano

@ZamielJC

152d

@PeterDiamandis @ThroneBiotech How much did this cost?
@grok guess

Peter H. Diamandis, MD

@PeterDiamandis

152d

Undergoing “StemCell reeducation” ⁦@ThroneBiotech⁩ - processed 10L of blood, extracting 300cc of white cells. Tonight those cells are co-incubated with cord blood stem cells to bring them to factory reset. I get them back tomorrow!!

The statement discusses the cost and potential future pricing of longevity therapies, touching on issues of accessibility and healthcare economics. It expresses hope for reduced costs through increased volume, which aligns with promoting understanding and empathy regarding healthcare access.

Principle 1:
I will strive to do no harm with my words and actions.
The statement does not cause harm and discusses potential benefits of reduced costs. [+1]
Principle 3:
I will use my words and actions to promote understanding, empathy, and compassion.
It promotes understanding and empathy by addressing the issue of accessibility to expensive therapies. [+1]